ArticleClinical kidney journal2024

Basiliximab induction alone vs a dual ATG-basiliximab approach in first live-donor non-sensitized kidney transplant recipients with low HLA matching.

Tammy Hod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.